What This Bill Does · Plain English
Summary · Congress.gov
Vietnam Veterans Liver Fluke Cancer Study Act This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents. The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.
Vote Breakdown · How Congress voted on HR.586
House
411-0
PASSED
Democrats
204 yea
0 nay
Republicans
204 yea
0 nay
Independents
3 yea
0 nay
Action Timeline
2025-04-08
Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.
2025-04-07
Motion to reconsider laid on the table Agreed to without objection.
2025-04-07
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436)
2025-04-07
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 411 - 0 (Roll no. 89). (text: CR H1435-1436: 1)
2025-04-07
Considered as unfinished business. (consideration: CR H1441-1442)
2025-04-07
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
2025-04-07
DEBATE - The House proceeded with forty minutes of debate on H.R. 586.
2025-04-07
Considered under suspension of the rules. (consideration: CR H1435-1437)
2025-04-07
Mr. Bost moved to suspend the rules and pass the bill, as amended.
2025-02-25
Referred to the Subcommittee on Health.
Frequently Asked Questions
Did HR.586 pass?
HR.586 is still alive. Current stage: COMMITTEE. Pass likelihood: 67%.
What does HR.586 do?
Vietnam Veterans Liver Fluke Cancer Study Act This bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents. The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up…
Who sponsored HR.586?
HR.586 was sponsored by Nick LaLota (R-New York).
Full Bill Text
119 HR 586 EH: Vietnam Veterans Liver Fluke Cancer Study Act U.S. House of Representatives text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 586 IN THE HOUSE OF REPRESENTATIVES AN ACT To direct the Secretary of Veterans Affairs to study and report on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era, and for other purposes. 1. Short title This Act may be cited as the Vietnam Veterans Liver Fluke Cancer Study Act . 2. Study on the prevalence of cholangiocarcinoma in veterans who served in the Vietnam theater of operations during the Vietnam era (a) Epidemiological study Not later than 120 days after the date of enactment of this Act, the Secretary of Veterans Affairs, in consultation with the Director of the Centers for Disease Control and Prevention of the Department of Health and Human Services, shall commence an epidemiological study on the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era, using data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The study shall include— (1) an identification of the rate of incidence of cholangiocarcinoma in covered veterans of the Vietnam era and in residents of the United States, from the beginning of the Vietnam era to the date of enactment of this Act; and (2) for each of the groups specified in paragraph (1), an identification of the percentage of individuals with cholangiocarcinoma by various demographic characteristics, including by age, gender, race, ethnicity, and the geographic location of the patient at the time of diagnosis. (b) Reports to Congress (1) Initial report Not later than one year after the completion of the study under subsection (a), the Secretary shall submit to Congress a report containing— (A) the results of the study under subsection (a); and (B) recommendations for administrative or legislative actions required to address issues identified in the study under subsection (a). (2) Follow-Up reports The Secretary shall periodically submit to the Congress a follow-up reports, as determined by the Secretary, to provide updates to the information included in the initial report under paragraph (1) and information collected pursuant to subsection (c). (c) Continued tracking of cholangiocarcinoma in covered veterans of the Vietnam era The Secretary shall track the prevalence of cholangiocarcinoma in covered veterans of the Vietnam era using the Veterans Affairs Central Cancer Registry, and provide such information to Congress in follow-up reports submitted under subsection (b)(2). (d) Definitions In this section: (1) The term Vietnam era has the meaning given such term in section 101 of title 38, United States Code. (2) The term covered veterans of the Vietnam era means veterans who served in the Vietnam theater of operations during the Vietnam era. 3. Extension of certain limitation of pension payments Section 5503(d)(7) of title 38, United States Code, is amended by striking November 30, 2031 and inserting December 31, 2031 . Passed the House of Representatives April 7, 2025. Kevin F. McCumber, Clerk.
Loading intelligence layer…